{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+comparison&page=27", "query": { "intervention": "Control comparison", "page": 27 }, "page_size": 10 }, "pagination": { "page": 27, "page_size": 10, "total_count": 4175, "total_pages": 418, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+comparison&page=28&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+comparison&page=26&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T09:30:18.157Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01158820", "title": "Alternative Sedation During Bronchoscopy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Sedation" ], "interventions": [ { "name": "Dexmedetomidine load", "type": "DRUG" }, { "name": "Ketamine load", "type": "DRUG" }, { "name": "Midazolam load", "type": "DRUG" }, { "name": "Fentanyl load", "type": "DRUG" }, { "name": "Dexmedetomidine maintenance", "type": "DRUG" }, { "name": "Ketamine maintenance", "type": "DRUG" }, { "name": "Midazolam demand", "type": "DRUG" }, { "name": "Fentanyl demand", "type": "DRUG" }, { "name": "Benadryl demand", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 50, "start_date": "2010-06", "completion_date": "2012-05", "has_results": true, "last_update_posted_date": "2019-02-26", "last_synced_at": "2026-11-15T09:30:18.157Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01158820" }, { "nct_id": "NCT01986920", "title": "Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Seborrheic Keratosis (SK)" ], "interventions": [ { "name": "A-101 25%", "type": "DRUG" }, { "name": "A-101 32.5%", "type": "DRUG" }, { "name": "A-101 40%", "type": "DRUG" }, { "name": "A-101 Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aclaris Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 35, "start_date": "2013-10-22", "completion_date": "2014-02-25", "has_results": true, "last_update_posted_date": "2018-12-11", "last_synced_at": "2026-11-15T09:30:18.157Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01986920" }, { "nct_id": "NCT01223027", "title": "Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Metastatic Renal Cell Carcinoma" ], "interventions": [ { "name": "Dovitinib", "type": "DRUG" }, { "name": "Sorafenib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 564, "start_date": "2011-03", "completion_date": "2014-06", "has_results": true, "last_update_posted_date": "2015-12-07", "last_synced_at": "2026-11-15T09:30:18.157Z", "location_count": 34, "location_summary": "Fayetteville, Arkansas • La Jolla, California • Los Angeles, California + 26 more", "locations": [ { "city": "Fayetteville", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01223027" }, { "nct_id": "NCT00361569", "title": "A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Menopause" ], "interventions": [ { "name": "DR-2041a", "type": "DRUG" }, { "name": "DR-2041b", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Duramed Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "80 Years", "sex": "FEMALE", "summary": "30 Years to 80 Years · Female only" }, "enrollment_count": 622, "start_date": "2006-08", "completion_date": "2007-09", "has_results": true, "last_update_posted_date": "2015-04-20", "last_synced_at": "2026-11-15T09:30:18.157Z", "location_count": 97, "location_summary": "Huntsville, Alabama • Mobile, Alabama • Montgomery, Alabama + 77 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00361569" }, { "nct_id": "NCT02260791", "title": "A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Arthritis, Rheumatoid" ], "interventions": [ { "name": "FKB327", "type": "DRUG" }, { "name": "Humira®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Fujifilm Kyowa Kirin Biologics Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 728, "start_date": "2014-12", "completion_date": "2016-07", "has_results": true, "last_update_posted_date": "2017-11-28", "last_synced_at": "2026-11-15T09:30:18.157Z", "location_count": 16, "location_summary": "Peoria, Arizona • Palm Desert, California • Boca Raton, Florida + 13 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Palm Desert", "state": "California" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Brandon", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02260791" }, { "nct_id": "NCT04854096", "title": "Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Primary Myelofibrosis", "Post-essential Thrombocythemia Myelofibrosis", "Post-polycythemia Vera Myelofibrosis" ], "interventions": [ { "name": "NS-018", "type": "DRUG" }, { "name": "Best Available Therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NS Pharma, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7, "start_date": "2023-01-31", "completion_date": "2024-05-16", "has_results": true, "last_update_posted_date": "2025-05-23", "last_synced_at": "2026-11-15T09:30:18.157Z", "location_count": 3, "location_summary": "Worcester, Massachusetts • Houston, Texas", "locations": [ { "city": "Worcester", "state": "Massachusetts" }, { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04854096" }, { "nct_id": "NCT05967442", "title": "Magnesium Versus Prochlorperazine Versus Metoclopramide for Migraines", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Migraine", "Headache" ], "interventions": [ { "name": "Magnesium Sulfate", "type": "DRUG" }, { "name": "Metoclopramide 10mg", "type": "DRUG" }, { "name": "Prochlorperazine (Compazine) Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 157, "start_date": "2019-08-23", "completion_date": "2023-04-06", "has_results": true, "last_update_posted_date": "2024-10-08", "last_synced_at": "2026-11-15T09:30:18.157Z", "location_count": 1, "location_summary": "Oak Lawn, Illinois", "locations": [ { "city": "Oak Lawn", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05967442" }, { "nct_id": "NCT05113160", "title": "Conversation Group Treatment for Aphasia: Does it Work?", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Aphasia, Acquired" ], "interventions": [ { "name": "Conversation Treatment for Aphasia", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Boston University Charles River Campus", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 162, "start_date": "2022-04-15", "completion_date": "2026-04-30", "has_results": false, "last_update_posted_date": "2025-02-06", "last_synced_at": "2026-11-15T09:30:18.157Z", "location_count": 3, "location_summary": "Boston, Massachusetts • Maywood, New Jersey • Philadelphia, Pennsylvania", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Maywood", "state": "New Jersey" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05113160" }, { "nct_id": "NCT02487888", "title": "A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain", "Chronic Pain", "Mental Disorders", "Cardiovascular Diseases", "Diabetes Mellitus, Type 2", "Arthritis" ], "interventions": [ { "name": "Unblinded to Genetic Testing Results", "type": "OTHER" }, { "name": "Blinded to Genetic Testing Results", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Proove Bioscience, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100000, "start_date": "2014-09", "completion_date": "2016-12", "has_results": false, "last_update_posted_date": "2016-03-30", "last_synced_at": "2026-11-15T09:30:18.157Z", "location_count": 31, "location_summary": "Beverly Hills, California • Fresno, California • La Jolla, California + 23 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02487888" }, { "nct_id": "NCT06965296", "title": "AI-Enhanced App-based Intervention for Adolescent E-cigarette Cessation", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Nicotine Dependence, Cigarettes" ], "interventions": [ { "name": "AI-enhanced smartphone app", "type": "BEHAVIORAL" }, { "name": "AI-enhanced smartphone app, but with delayed access", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "State University of New York at Buffalo", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "14 Years", "maximum_age": "20 Years", "sex": "ALL", "summary": "14 Years to 20 Years" }, "enrollment_count": 100, "start_date": "2026-08-24", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-08-06", "last_synced_at": "2026-11-15T09:30:18.157Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06965296" } ] }